Multilineage Potential of Adult Human Mesenchymal Stem Cells
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Human mesenchymal stem cells are thought to be multipotent cells, which are present in adult marrow, that can replicate as undifferentiated cells and that have the potential to differentiate to lineages of mesenchymal tissues, including bone, cartilage, fat, tendon, muscle, and marrow stroma. Cells that have the characteristics of human mesenchymal stem cells were isolated from marrow aspirates of volunteer donors. These cells displayed a stable phenotype and remained as a monolayer in vitro. These adult stem cells could be induced to differentiate exclusively into the adipocytic, chondrocytic, or osteocytic lineages. Individual stem cells were identified that, when expanded to colonies, retained their multilineage potential.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additionally, harvesting BM-MSCs is limited by the potential pain and morbidity associated with bone marrow aspiration, and only a small fraction (0.001–0.01%) of harvested bone marrow cells are MSCs [58,67].”
From Mesenchymal Stem/Stromal Cells: Immunomodulatory and Bone Regeneration Potential after Tumor Excision in Osteosarcoma Patients (2023) · cites this paper as [67]
Citations
Cites
Embryonic Stem Cell Lines Derived from Human Blastocysts
Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S., & Jones, J. M. (1998) · Science · doi:10.1126/science.282.5391.1145 · Cited by 15,926
Caplan, A. I. (1991) · Journal of Orthopaedic Research · doi:10.1002/jor.1100090504 · Cited by 6,548
Marrow Stromal Cells as Stem Cells for Nonhematopoietic Tissues
Prockop, D. J. (1997) · Science · doi:10.1126/science.276.5309.71 · Cited by 4,629
A Direct Measurement of the Radiation Sensitivity of Normal Mouse Bone Marrow Cells1
Till, J. E., & McCulloch, E. A. (2011) · Radiation Research · doi:10.1667/rrxx28.1 · Cited by 4,036
A Direct Measurement of the Radiation Sensitivity of Normal Mouse Bone Marrow Cells
Till, J. E., & McCulloch, E. A. (1961) · Radiation Research · doi:10.2307/3570892 · Cited by 3,708
In VitroChondrogenesis of Bone Marrow-Derived Mesenchymal Progenitor Cells
Johnstone, B., Hering, T. M., Caplan, A. I., Goldberg, V. M., & Yoo, J. U. (1998) · Experimental Cell Research · doi:10.1006/excr.1997.3858 · Cited by 2,382
Mesenchymal cell-based repair of large, full-thickness defects of articular cartilage.
Wakitani, S., Goto, T., Pineda, S. J., Young, R. G., Mansour, J. M., Caplan, A. I., & Goldberg, V. M. (1994) · The Journal of Bone & Joint Surgery · doi:10.2106/00004623-199404000-00013 · Cited by 1,605
Bruder, S. P., Jaiswal, N., & Haynesworth, S. E. (1997) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(199702)64:2<278::aid-jcb11>3.0.co;2-f · Cited by 1,485
Derivation of pluripotent stem cells from cultured human primordial germ cells
Shamblott, M. J., Axelman, J., Wang, S., Bugg, E. M., Littlefield, J. W., Donovan, P. J., Blumenthal, P. D., Huggins, G. R., & Gearhart, J. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13726 · Cited by 1,420
Circulating Fibrocytes Define a New Leukocyte Subpopulation That Mediates Tissue Repair
Bucala, R., Spiegel, L. A., Chesney, J., Hogan, M., & Cerami, A. (1994) · Molecular Medicine · doi:10.1007/bf03403533 · Cited by 1,308
Research works printed but not linked: 4
- ; M. Owen and A. J. Friedenstein in Cell and Molecular Biology of Vertebrate Hard Tissues D. Evered and S. Harnett Eds. (Wiley Chichester UK 1988) pp. 42–60.
- Friedenstein A. J., Chailakhyan R. K., Gerasimov U. V., Cell Tissue Kinet. 20, 263 (1987);
- Bab I., Howlett C. R., Ashton B. A., Owen M. E., ibid. 187, 243 (1984).
- We thank D. Fink J. Andres R. Deans F. Barry S Bruder M. Thiede A. Moseley and J. Burns for discussion and review of the manuscript; M. Black and M. Earlington for cell isolation from marrow; and D. Sterchi D. Brown and J. Skwarek for histology. This work was supported by Osiris Therapeutics (www.osiristx.com) and in part by a research contract from the Defense Advanced Research Projects Agency.
Cited by
Items 1,501–1,600 of 1,649
Thompson, E. M., Matsiko, A., Farrell, E., Kelly, D. J., & O'Brien, F. J. (2015) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.1918 · Cited by 147
“…self-renewal capacity and ability to secrete a range of cytokines and growth factors, whichmediate cellular activity and suppress the immunological response through inhibition of TNFα and IFNγ secretion (Pittenger et al., 1999; Beyth et al., 2005; Caplan, 2007; Sacchetti et al., 2007).”
García-Bernal, D., García-Arranz, M., Yáñez, R. M., Hervás-Salcedo, R., Cortés, A., Fernández-García, M., Hernando-Rodríguez, M., Quintana-Bustamante, Ó., Bueren, J. A., García-Olmo, D., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.650664 · Cited by 138
Ikoma, T., Kyo, S., Maida, Y., Ozaki, S., Takakura, M., Nakao, S., & Inoue, M. (2009) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2009.07.026 · Cited by 137
Kwon, Y. W., Heo, S. C., Jeong, G. O., Yoon, J. W., Mo, W. M., Lee, M. J., Jang, I.-H., Kwon, S. M., Lee, J. S., & Kim, J. H. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.08.002 · Cited by 137
“They possess stem cell properties, such as self renewal capacity, long term viability, and potential for differentiation into mesodermal lineages, including adipocytes, osteocytes, chondrocytes, and muscle cells [10–12].”
BackgroundLee, E. J., Park, S. J., Kang, S. K., Kim, G.-H., Kang, H.-J., Lee, S.-W., Jeon, H. B., & Kim, H.-S. (2012) · Molecular Therapy · doi:10.1038/mt.2012.58 · Cited by 136
Liebergall, M., Schroeder, J., Mosheiff, R., Gazit, Z., Yoram, Z., Rasooly, L., Daskal, A., Khoury, A., Weil, Y., & Beyth, S. (2013) · Molecular Therapy · doi:10.1038/mt.2013.109 · Cited by 134
Chen, Y., Yang, S., Lovisa, S., Ambrose, C. G., McAndrews, K. M., Sugimoto, H., & Kalluri, R. (2021) · Nature Communications · doi:10.1038/s41467-021-27563-3 · Cited by 134
Alnahdi, A., John, A., & Raza, H. (2019) · Nutrients · doi:10.3390/nu11091979 · Cited by 134
Park, B.-W., Jung, S.-H., Das, S., Lee, S. M., Park, J.-H., Kim, H., Hwang, J.-W., Lee, S., Kim, H.-J., Kim, H.-Y., et al. (2020) · Science Advances · doi:10.1126/sciadv.aay6994 · Cited by 133
Ablation of the Sam68 RNA Binding Protein Protects Mice from Age-Related Bone Loss
Richard, S., Torabi, N., Franco, G. V., Tremblay, G. A., Chen, T., Vogel, G., Morel, M., Cléroux, P., Forget-Richard, A., Komarova, S., et al. (2005) · PLoS Genetics · doi:10.1371/journal.pgen.0010074 · Cited by 133
“]. Osteoblasts and adipocytes are derived from a common mesenchymal precursor cell present in bone marrow, and the factors that control this age-induced switch toward adipogenic differentiation is not well understood [”
BackgroundHow does spaceflight affect the acquired immune system?
Akiyama, T., Horie, K., Hinoi, E., Hiraiwa, M., Kato, A., Maekawa, Y., Takahashi, A., & Furukawa, S. (2020) · npj Microgravity · doi:10.1038/s41526-020-0104-1 · Cited by 132
PI3K/Akt signaling pathway is essential for de novo hair follicle regeneration
Chen, Y., Fan, Z., Wang, X., Mo, M., Zeng, S. B., Xu, R.-H., Wang, X., & Wu, Y. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-01650-6 · Cited by 130
The (in) auspicious role of mesenchymal stromal cells in cancer: be it friend or foe
Kidd, S., Spaeth, E., Klopp, A., Andreeff, M., Hall, B., & Marini, F. (2008) · Cytotherapy · doi:10.1080/14653240802486517 · Cited by 128
Mesenchymal stem cell transplantation in multiple sclerosis
Cohen, J. A. (2013) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2012.12.009 · Cited by 127
“Besides hematopoietic stem cells, the bone marrow (BM) microenvironment contains pluripotent non-hematopoietic precursor cells that can be isolated, culture-expanded to purity, and induced to differentiate in vitro and in vivo into mesodermal derivatives [1,2].”
BackgroundEfficient lung cancer-targeted drug delivery via a nanoparticle/MSC system
Wang, X., Chen, H., Zeng, X., Guo, W., Jin, Y., Wang, S., Tian, R., Han, Y., Guo, L., Han, J., et al. (2019) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2018.08.006 · Cited by 126
Progress, obstacles, and limitations in the use of stem cells in organ-on-a-chip models
Wnorowski, A., Yang, H., & Wu, J. C. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.06.001 · Cited by 124
Mesenchymal stem cells in preclinical cancer cytotherapy: a systematic review
Christodoulou, I., Goulielmaki, M., Devetzi, M., Panagiotidis, M., Koliakos, G., & Zoumpourlis, V. (2018) · Stem Cell Research & Therapy · doi:10.1186/s13287-018-1078-8 · Cited by 122
Mesenchymal stromal cells in hepatic fibrosis/cirrhosis: from pathogenesis to treatment
Yang, X., Li, Q., Liu, W., Zong, C., Wei, L., Shi, Y., & Han, Z. (2023) · Cellular & Molecular Immunology · doi:10.1038/s41423-023-00983-5 · Cited by 120
“MSCs are considered to be the most promising cells for cell therapy due to the following properties: (1) they are easy to obtain from various tissues and easy to expand in vitro without changing their properties [8, 10] (2) they allow for allogeneic transplantation because of their low immunogenicity and lack of ethic…”
BackgroundInfluentialCirculating plastic adherent mesenchymal stem cells in aged hip fracture patients
Alm, J. J., Koivu, H. M. A., Heino, T. J., Hentunen, T. A., Laitinen, S., & Aro, H. T. (2010) · Journal of Orthopaedic Research · doi:10.1002/jor.21167 · Cited by 119
Cell delivery therapeutics for musculoskeletal regeneration☆
Nöth, U., Rackwitz, L., Steinert, A. F., & Tuan, R. S. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.04.004 · Cited by 119
Song, J., Liu, J., Cui, C., Hu, H., Zang, N., Yang, M., Yang, J., Zou, Y., Li, J., Wang, L., et al. (2023) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.13177 · Cited by 118
Quirici, N., Scavullo, C., de Girolamo, L., Lopa, S., Arrigoni, E., Deliliers, G. L., & Brini, A. T. (2010) · Stem Cells and Development · doi:10.1089/scd.2009.0408 · Cited by 117
“MSCs have been initially identifi ed in bone marrow (BM) [ 1 ], but have been subsequently isolated from many other tissues [ 2–10 ].”
Bastos, R., Mathias, M., Andrade, R., Amaral, R. J. F. C., Schott, V., Balduino, A., Bastos, R., Miguel Oliveira, J., Reis, R. L., Rodeo, S., et al. (2020) · Knee Surgery, Sports Traumatology, Arthroscopy · doi:10.1007/s00167-019-05732-8 · Cited by 117
Role of MSC in the Tumor Microenvironment
Hass, R. (2020) · Cancers · doi:10.3390/cancers12082107 · Cited by 116
“MSC are defined to share some common basic properties such as in vitro plastic adherence; simultaneous expression of the surface markers CD73, CD90 and CD105l; and in vitro differentiation capacity, at least along osteogenic, adipogenic and chondrogenic lineages [1,16,18].”
BackgroundThe Metabolic Microenvironment Steers Bone Tissue Regeneration
Loeffler, J., Duda, G. N., Sass, F. A., & Dienelt, A. (2018) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2017.11.008 · Cited by 113
Yang, X.-F., He, X., He, J., Zhang, L.-H., Su, X.-J., Dong, Z.-Y., Xu, Y.-J., Li, Y., & Li, Y.-L. (2011) · Journal of Biomedical Science · doi:10.1186/1423-0127-18-59 · Cited by 112
“Mesenchymal stem cells have been widely used in experimental and clinical research because of their unique biological characteristics and advantages [1-4].”
BackgroundJaved, M. J., Mead, L. E., Prater, D., Bessler, W. K., Foster, D., Case, J., Goebel, W. S., Yoder, M. C., Haneline, L. S., & Ingram, D. A. (2008) · Pediatric Research · doi:10.1203/pdr.0b013e31817445e9 · Cited by 105
“Therefore, we next tested whether the cell progeny generated from the colonies yielded each cell type utilizing previously established methods (20).”
BackgroundMethodTransplanting Mesenchymal Stem Cells for Treatment of Ischemic Stroke
Wang, F., Tang, H., Zhu, J., & Zhang, J. H. (2018) · Cell Transplantation · doi:10.1177/0963689718795424 · Cited by 102
Liu, J., Hao, H., Xia, L., Ti, D., Huang, H., Dong, L., Tong, C., Hou, Q., Zhao, Y., Liu, H., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0126715 · Cited by 101
“Mesenchymal stem cells have been isolated from bone marrow, adipose tissue, and other adult tissues [32].”
BackgroundChan, R. W. S., Ng, E. H. Y., & Yeung, W. S. B. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.02.025 · Cited by 98
“To assess the multipotency, protocols for in vitro differentiation were adapted from those of Pittenger et al.(21) Large Table 1.”
MethodCervelló, I., Gil-Sanchis, C., Mas, A., Faus, A., Sanz, J., Moscardó, F., Higueras, G., Sanz, M. A., Pellicer, A., & Simón, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030260 · Cited by 99
“Bone marrow (BM) cells are able to differentiate into multiple nonhematopoietic cells”
BackgroundPotential implications of mesenchymal stem cells in cancer therapy
Dai, L.-J., Moniri, M. R., Zeng, Z.-R., Zhou, J. X., Rayat, J., & Warnock, G. L. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.02.012 · Cited by 99
“Furthermore, MSCs have generated considerable biomedical interest since their multi-lineage potential was first identified in 1999 [4].”
BackgroundDulic, O., Rasovic, P., Lalic, I., Kecojevic, V., Gavrilovic, G., Abazovic, D., Maric, D., Miskulin, M., & Bumbasirevic, M. (2021) · Medicina · doi:10.3390/medicina57111193 · Cited by 99
Regenerative therapy after cancer: what are the risks?
Donnenberg, V. S., Zimmerlin, L., Rubin, J. P., & Donnenberg, A. D. (2010) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2010.0352 · Cited by 95
Ghali, O., Broux, O., Falgayrac, G., Haren, N., van Leeuwen, J. P., Penel, G., Hardouin, P., & Chauveau, C. (2015) · BMC Cell Biology · doi:10.1186/s12860-015-0056-6 · Cited by 95
“mesenchymal stem cell (MSC) progenitor [6-8], the involvement of a competition between these two differentiation pathways in the decrease of osteoblastic cell population described in osteoporotic bone specimen is often evoked.”
BackgroundHildebrandt, C., Büth, H., Cho, S., Impidjati, & Thielecke, H. (2010) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2010.01.007 · Cited by 95
Lei, L., Bruneau, A., El Mourabit, H., Guégan, J., Folseraas, T., Lemoinne, S., Karlsen, T. H., Hoareau, B., Morichon, R., Gonzalez‐Sanchez, E., et al. (2022) · Hepatology · doi:10.1002/hep.32456 · Cited by 94
“MSCs were first identified in the bone marrow as clonogenic, multipotent cells able to differentiate into lineages of mesenchymal tissues including osteoblasts, chondrocytes, and adipocytes in culture.[34] Subsequently, cells with similar properties were identified in multiple organs and also referred to as MSCs.”
BackgroundTabe, Y., Konopleva, M., Munsell, M. F., Marini, F. C., Zompetta, C., McQueen, T., Tsao, T., Zhao, S., Pierce, S., Igari, J., et al. (2004) · Blood · doi:10.1182/blood-2003-03-0802 · Cited by 93
Liang, J., Zhang, H., Zhao, C., Wang, D., Ma, X., Zhao, S., Wang, S., Niu, L., & Sun, L. (2017) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.13015 · Cited by 93
Corti, S., Locatelli, F., Donadoni, C., Strazzer, S., Salani, S., Del Bo, R., Caccialanza, M., Bresolin, N., Scarlato, G., & Comi, G. P. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10455 · Cited by 91
“Bone marrow (BM) stem cells not only may differentiate into mesodermal cells, such as bone, cartilage, adipocytes (Pittenger et al., 1999), and cardiac (Orlic et al.”
BackgroundSeebach, E., Freischmidt, H., Holschbach, J., Fellenberg, J., & Richter, W. (2014) · Acta Biomaterialia · doi:10.1016/j.actbio.2014.07.017 · Cited by 92
Eiró, N., Sendon-Lago, J., Seoane, S., Bermúdez, M. A., Lamelas, M. L., Garcia-Caballero, T., Schneider, J., Perez-Fernandez, R., & Vizoso, F. J. (2014) · Oncotarget · doi:10.18632/oncotarget.2530 · Cited by 92
“Human mesenchymal stem/stromal cells (MSCs) are multipotent cells that possess the capability for selfrenewal and are able to differentiate into several types of mesenchymal cells including adipocytes, osteoblasts, and chondrocytes [9-11].”
Mesenchymal stem/stromal cells in post-menopausal endometrium
Ulrich, D., Tan, K. S., Deane, J., Schwab, K., Cheong, A., Rosamilia, A., & Gargett, C. E. (2014) · Human Reproduction · doi:10.1093/humrep/deu159 · Cited by 91
“Originally MSC were identified by their adherence to plastic and differentiation into mesodermal lineages: adipocytic, chondrocytic and osteoblastic (Prockop 1997; Pittenger et al., 1999).”
BackgroundHonoki, K. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1220 · Cited by 90
Neo-Organoid of Marrow Mesenchymal Stromal Cells Secreting Interleukin-12 for Breast Cancer Therapy
Eliopoulos, N., Francois, M., Boivin, M.-N., Martineau, D., & Galipeau, J. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0160 · Cited by 90
Vedrenne, N., Coulomb, B., Danigo, A., Bonté, F., & Desmoulière, A. (2012) · Pathologie Biologie · doi:10.1016/j.patbio.2011.10.002 · Cited by 89
Andrzejewska, A., Catar, R., Schoon, J., Qazi, T. H., Sass, F. A., Jacobi, D., Blankenstein, A., Reinke, S., Krüger, D., Streitz, M., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02474 · Cited by 89
“(84), themajority of studies on BMSCs have assessed multilineage differentiation potential as part of the minimal criteria for their characterization (69).”
BackgroundCell differentiation through tissue elasticity-coupled, myosin-driven remodeling
Zajac, A. L., & Discher, D. E. (2008) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2008.09.006 · Cited by 88
“Adhesion occurs within hours [31] and is likely mediated by serum matrix proteins such as fibronectin that commonly adsorb rapidly to plastic and are also prominent in bone marrow.”
Hao, Z., Wang, S., Zhang, X., & Lu, J. (2016) · Cell Proliferation · doi:10.1111/cpr.12242 · Cited by 88
Teixeira, F. G., Panchalingam, K. M., Anjo, S. I., Manadas, B., Pereira, R., Sousa, N., Salgado, A. J., & Behie, L. A. (2015) · Stem Cell Research & Therapy · doi:10.1186/s13287-015-0124-z · Cited by 87
“The use of adult stem cells, including human mesenchymal stem cells (hMSCs), as a possible therapeutic tool in the regenerative medicine field has been widely assessed [1–3], and has emerged as a promising therapeutic approach [4–6].”
BackgroundZhao, N., Wang, X., Qin, L., Guo, Z., & Li, D. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.08.061 · Cited by 87
Bielohuby, M., Matsuura, M., Herbach, N., Kienzle, E., Slawik, M., Hoeflich, A., & Bidlingmaier, M. (2010) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.090813 · Cited by 85
“Shifting differentiation and survival rates from the osteoblastic to the adipocytic lineage thus could result in an altered bone mass.((24)) Since we found a lower BMD in rats fed LC-HF diets, we analyzed markers of bone formation and osteoblast activity, respectively.”
BackgroundXu, C., Ren, G., Cao, G., Chen, Q., Shou, P., Zheng, C., Du, L., Han, X., Jiang, M., Yang, Q., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.414862 · Cited by 84
“Mesenchymal stem cells (MSCs)(4) exist in almost all tissues and have been isolated from bone marrow, adipose tissue, umbilical cord, and amniotic fluid and successfully expanded in vitro (1, 2).”
BackgroundReview of Mesenchymal Stem Cells and Tumors: Executioner or Coconspirator?
Feng, B., & Chen, L. (2009) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2009.0652 · Cited by 83
ZnO/Nanocarbons-Modified fibrous scaffolds for stem cell-based osteogenic differentiation
Xia, Y., Fan, X., Yang, H., Li, L., He, C., Cheng, C., & Haag, R. (2020) · Small · doi:10.1002/smll.202003010 · Cited by 79
Duan, X., Guan, H., Cao, Y., & Kleinerman, E. S. (2009) · Cancer · doi:10.1002/cncr.24013 · Cited by 79
“) as an indicator of intracellular lipid accumulation.(17,21) The cells were fixed with 10% formalin, washed, and stained with a working solution of 0.”
MethodYe, H., Cheng, J., Tang, Y., Liu, Z., Xu, C., Liu, Y., & Sun, Y. (2012) · Cancer Investigation · doi:10.3109/07357907.2012.692171 · Cited by 78
Petrenko, Y. A., Ivanov, R. V., Petrenko, A. Y., & Lozinsky, V. I. (2011) · Journal of Materials Science Materials in Medicine · doi:10.1007/s10856-011-4323-6 · Cited by 78
Bashir, S., Teo, Y. Y., Ramesh, S., Ramesh, K., & Khan, A. A. (2015) · Reviews in Chemical Engineering · doi:10.1515/revce-2015-0016 · Cited by 77
Peripheral nerve repair with cultured schwann cells: getting closer to the clinics
Rodrigues, M. C. O., Rodrigues, A. A., Glover, L. E., Voltarelli, J., & Borlongan, C. V. (2012) · The Scientific World Journal · doi:10.1100/2012/413091 · Cited by 75
“Mesenchymal stromal cells (MSCs) or bone marrow stromal cells are multipotent somatic stem cells, from a nonhematopoietic precursor anchored in bone marrow that can differentiate in mesodermal cell linages, neural phenotypes, and also into Schwann-like cells [47, 66].”
BackgroundSubstance P modulates bone remodeling properties of murine osteoblasts and osteoclasts
Niedermair, T., Schirner, S., Seebröker, R., Straub, R. H., & Grässel, S. (2018) · Scientific Reports · doi:10.1038/s41598-018-27432-y · Cited by 74
Calcium signalling in chondrogenesis implications for cartilage repair
Matta, C. (2013) · Frontiers in Bioscience · doi:10.2741/s374 · Cited by 74
“Originally isolated from bone marrow by Pittenger and colleagues in 1999 (2), somatic or adult mesenchymal stem cells (MSCs) have been described to differentiate into various connective tissue cells, including the chondrogenic lineage that can give rise to chondroblasts and chondrocytes (3).”
BackgroundLiu, T. M., Ng, W. M., Tan, H. S., Vinitha, D., Yang, Z., Fan, J. B., Zou, Y., Hui, J. H., Lee, E. H., & Lim, B. (2013) · Stem Cells and Development · doi:10.1089/scd.2012.0222 · Cited by 74
“MSCs are one of the most promising resources for cell and gene therapy because of versatile plasticity in vitro and in vivo [25].”
BackgroundRising Stars: Astrocytes as a Therapeutic Target for ALS Disease
Izrael, M., Slutsky, S. G., & Revel, M. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00824 · Cited by 73
Hofbauer, L., Hicok, K., Chen, D., & Khosla, S. (2002) · European Journal of Endocrinology · doi:10.1530/eje.0.1470269 · Cited by 72
“MD, USA) and were cultured in osteogenesis-induction medium containing 0.1mmol/l dexamethasone, 0.05 mmol/l ascorbic acid-2-phosphate, and 10 mmol/l b-glycerol phosphate for 14 days ( 17 ).”
BackgroundMethodInfluentialSomoza, R., Juri, C., Baes, M., Wyneken, U., & Rubio, F. J. (2010) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2010.06.006 · Cited by 72
“Bone marrow (BM) contains mesenchymal stem cells (MSCs), also termed multipotent stromal cells, with the ability to differentiate in vitro into mesenchymal and nonmesenchymal lineages, including neuronal and glial lineages [1-8].”
BackgroundBelmar-Lopez, C., Mendoza, G., Oberg, D., Burnet, J., Simon, C., Cervello, I., Iglesias, M., Ramirez, J. C., Lopez-Larrubia, P., Quintanilla, M., et al. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-139 · Cited by 71
Higuera, G., Schop, D., Janssen, F., van Dijkhuizen-Radersma, R., van Boxtel, T., & van Blitterswijk, C. A. (2009) · Tissue Engineering Part A · doi:10.1089/ten.tea.2008.0328 · Cited by 69
Li, X., Lu, Y., Huang, W., Xu, H., Chen, X., Geng, Q., Fan, H., Tan, Y., Xue, G., & Jiang, X. (2006) · Hematological Oncology · doi:10.1002/hon.779 · Cited by 68
“Purified and culture-expanded BMSCs are nonhematopoietic cells with the ability to differentiate into mutiple mesenchymal lineages that include osteoblasts, chondrocytes, adipocytes, andmyoblasts under appropriate conditions both in vitro [1,2] and in vivo [3–5].”
Hamidouche, Z., Fromigué, O., Nuber, U., Vaudin, P., Pages, J., Ebert, R., Jakob, F., Miraoui, H., & Marie, P. J. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22152 · Cited by 67
Orciani, M., Gorbi, S., Benedetti, M., Di Benedetto, G., Mattioli-Belmonte, M., Regoli, F., & Di Primio, R. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.06.007 · Cited by 67
“Mesenchymal stem cells (MSCs) might be of particular interest for the development of future therapeutic tools, because they can proliferate and differentiate into several mesenchymal lineage cells, such as osteoblasts, adipocytes, and chondrocytes [12,13] and, in vitro, also endothelial, neural, and hepatocytic cells…”
BackgroundHashimoto, J., Kariya, Y., & Miyazaki, K. (2006) · STEM CELLS · doi:10.1634/stemcells.2005-0605 · Cited by 67
Liu, X., Zhou, L., Chen, X., Liu, T., Pan, G., Cui, W., Li, M., Luo, Z.-P., Pei, M., Yang, H., et al. (2016) · Materials Science and Engineering: C · doi:10.1016/j.msec.2015.12.090 · Cited by 66
Mouse embryonic fibroblasts exhibit extensive developmental and phenotypic diversity
Singhal, P. K., Sassi, S., Lan, L., Au, P., Halvorsen, S. C., Fukumura, D., Jain, R. K., & Seed, B. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1522401112 · Cited by 66
“Heterogeneity is an attribute of multiple cell types, including many sources of MSCs (32–36), hematopoietic progenitors (37, 38), adult cardiac side populations (39), and side populations of skeletal muscle (40).”
ResultInfluentialPintore, A., Notarfrancesco, D., Zara, A., Oliviero, A., Migliorini, F., Oliva, F., & Maffulli, N. (2023) · Journal of Orthopaedic Surgery and Research · doi:10.1186/s13018-023-03841-2 · Cited by 65
“MSCs are multipotent cells that show strong self-renewal capabilities, with a differentiation ability to form chondrocytes, adipocytes, and osteocytes [22].”
BackgroundKim, D. S., Lee, M. W., Lee, T.-H., Sung, K. W., Koo, H. H., & Yoo, K. H. (2017) · Biomedical Reports · doi:10.3892/br.2017.845 · Cited by 65
Ardeshirylajimi, A., Mossahebi‐Mohammadi, M., Vakilian, S., Langroudi, L., Seyedjafari, E., Atashi, A., & Soleimani, M. (2015) · Cell Proliferation · doi:10.1111/cpr.12156 · Cited by 64
Localization of CD44 and CD90 positive cells to the invasive front of breast tumors
Donnenberg, V. S., Donnenberg, A. D., Zimmerlin, L., Landreneau, R. J., Bhargava, R., Wetzel, R. A., Basse, P., & Brufsky, A. M. (2010) · Cytometry Part B: Clinical Cytometry · doi:10.1002/cyto.b.20530 · Cited by 62
“CD44 is prominent on normal mesenchymal stem cells (34) and has been proposed to play a role in their migration and homing (35).”
BackgroundHu, X., Li, L., Yu, X., Zhang, R., Yan, S., Zeng, Z., Shu, Y., Zhao, C., Wu, X., Lei, J., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.22915 · Cited by 62
“While MSCs can be isolated from various tissues [2, 3, 25], MSCs isolated from the bone marrow, a subset of bone marrow stromal cells, are the most characterized [1, 5].”
BackgroundGao, L., Cai, G., & Shi, X. (2008) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.31.2245 · Cited by 61
Liu, Y., Kou, X., Chen, C., Yu, W., Su, Y., Kim, Y., Shi, S., & Liu, Y. (2016) · Stem Cells · doi:10.1002/stem.2392 · Cited by 61
Carvalho, M. S., Alves, L., Bogalho, I., Cabral, J. M. S., & da Silva, C. L. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.747521 · Cited by 61
Mesenchymal stem cells inhibit T-cell function through conserved induction of cellular stress
Laing, A. G., Fanelli, G., Ramirez-Valdez, A., Lechler, R. I., Lombardi, G., & Sharpe, P. T. (2019) · PLOS ONE · doi:10.1371/journal.pone.0213170 · Cited by 59
“Mesenchymal stem cells (MSCs) is the generic name given to tissue-resident adult stromal stem cells that are capable of differentiating into a number of mesodermal lineages in vitro [1].”
BackgroundHuman cells with osteogenic potential in bone tissue research
Dvorakova, J., Wiesnerova, L., Chocholata, P., Kulda, V., Landsmann, L., Cedikova, M., Kripnerova, M., Eberlova, L., & Babuska, V. (2023) · BioMedical Engineering OnLine · doi:10.1186/s12938-023-01096-w · Cited by 58
“, by puncture from the hip ridge [102], or in a non-invasive manner, i.”
BackgroundChen, X., Li, M., Yan, J., Liu, T., Pan, G., Yang, H., Pei, M., & He, F. (2017) · Alcohol and Alcoholism · doi:10.1093/alcalc/agx006 · Cited by 56
Rath, S. N., Nooeaid, P., Arkudas, A., Beier, J. P., Strobel, L. A., Brandl, A., Roether, J. A., Horch, R. E., Boccaccini, A. R., & Kneser, U. (2016) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.1849 · Cited by 55
“With respect to the number of stromal cells, the number of MSCs in bone marrow is very low; whereas in adipose tissue this number is much higher (Pittenger et al., 1999; Zuk et al., 2002).”
BackgroundZHANG, P., DONG, L., YAN, K., LONG, H., YANG, T.-T., DONG, M.-Q., ZHOU, Y., FAN, Q.-Y., & MA, B.-A. (2013) · Oncology Reports · doi:10.3892/or.2013.2619 · Cited by 54
“MSCs were isolated and expanded according to a modification of a previously described protocol (11,12).”
MethodWang, J., Bian, C., Liao, L., Zhu, Y., Li, J., Zeng, L., & Zhao, R. C. (2009) · Hepatology Research · doi:10.1111/j.1872-034x.2009.00564.x · Cited by 54
Han, S. H., Cha, M., Jin, Y.-Z., Lee, K.-M., & Lee, J. H. (2021) · Biomedical Materials · doi:10.1088/1748-605x/aba879 · Cited by 53
Glucose Metabolism in Osteoblasts in Healthy and Pathophysiological Conditions
Donat, A., Knapstein, P.-R., Jiang, S., Baranowsky, A., Ballhause, T.-M., Frosch, K.-H., & Keller, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084120 · Cited by 53
Kerpedjieva, S. S., Kim, D. S., Barbeau, D. J., & Tamama, K. (2012) · Stem Cells and Development · doi:10.1089/scd.2011.0711 · Cited by 53
IFN-γ-Secreting-Mesenchymal Stem Cells Exert an Antitumor Effect In Vivo via the TRAIL Pathway
Yang, X., Du, J., Xu, X., Xu, C., & Song, W. (2014) · Journal of Immunology Research · doi:10.1155/2014/318098 · Cited by 52
Roorda, B. D., Elst, A. T., Boer, T. G. J. M.-D., Kamps, W. A., & de Bont, E. S. J. M. (2010) · Cancer Investigation · doi:10.3109/07357900903179625 · Cited by 51
Bosco, D. B., Kenworthy, R., Zorio, D. A. R., & Sang, Q.-X. A. (2015) · PLOS ONE · doi:10.1371/journal.pone.0128511 · Cited by 50
“Human adult mesenchymal stem cells (hMSCs) are a class of multi-potent cells that can readily differentiate into adipocytes, chondrocytes, and osteoblasts [1].”
BackgroundRagni, E., Montemurro, T., Montelatici, E., Lavazza, C., Viganò, M., Rebulla, P., Giordano, R., & Lazzari, L. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2013.04.002 · Cited by 48
Chen, D., Tang, P., Liu, L., Wang, F., Xing, H., Sun, L., & Jiang, Z. (2018) · Cell Cycle · doi:10.1080/15384101.2018.1442624 · Cited by 48
Sadie-Van Gijsen, H., Hough, F. S., & Ferris, W. F. (2013) · Bone · doi:10.1016/j.bone.2013.06.016 · Cited by 48
Human adipose tissue derived mesenchymal stem cells are resistant to several chemotherapeutic agents
Liang, W., Xia, H., Li, J., & Zhao, R. C. (2011) · Cytotechnology · doi:10.1007/s10616-011-9374-5 · Cited by 47
“They can differentiate into various cell lineages including osteoblasts, chondrocytes, adipocytes and other cell types (Kopen et al. 1999; Liechty et al. 2000; Muraglia et al. 2000; Pereira et al. 1998; Pittenger et al. 1999; Toma et al. 2002; Wakitani et al. 1995; Woodbury et al. 2000).”
BackgroundShi, Y., Xia, Y.-Y., Wang, L., Liu, R., Khoo, K.-S., & Feng, Z.-W. (2012) · Experimental Cell Research · doi:10.1016/j.yexcr.2012.05.029 · Cited by 45
“Recently, NCAM was also found to be expressed in MSCs, a promising tool in tissue engineering as well as multiple cellular and gene therapies owing to their multipotentiality [11] and ability to mobilize and specifically localize to tumor [12,13] and injury sites [14,15].”
Lamas, J. R., Rodríguez-Rodríguez, L., Vigo, A. G., Álvarez-Lafuente, R., López-Romero, P., Marco, F., Camafeita, E., Dopazo, A., Callejas, S., Villafuertes, E., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.122564 · Cited by 43
Metadata
- Authors
- Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., Moorman, M. A., Simonetti, D. W., Craig, S., & Marshak, D. R.
- Affiliations
- Osiris Therapeutics (United States) (US)
- Johns Hopkins University (US)
- Corresponding author
- Pittenger, Mark F.
- ORCID
- Pittenger, Mark F.
- Venue
- Science
- Published
- 1999-04-02
- Volume
- 284
- Issue
- 5411
- Pages
- 143-147
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2159999899
- Cited by
- 21,052
- References
- 37
- Citations by year
- 2026: 265 · 2025: 373 · 2024: 497 · 2023: 541 · 2022: 604 · 2021: 778 · 2020: 856 · 2019: 766 · 2018: 884 · 2017: 962 · 2016: 1083 · 2015: 1145 · 2014: 1255 · 2013: 1344 · 2012: 1384
- FWCI
- 138.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Keywords
- mesenchymal stem cells, multilineage differentiation, multipotency, bone marrow, adipogenesis, chondrogenic differentiation, osteogenic differentiation, stem cell isolation, colony expansion, stem cell phenotype
- MeSH terms
- Adult, Bone Marrow Cells, Cell Differentiation, Cell Division, Cell Separation, Cells, Cultured, Fibroblasts, Flow Cytometry, Humans, Mesoderm, Middle Aged, Osteocytes, Phenotype, Stem Cells, Apoptosis, Adipocytes, Cell Lineage, Chondrocytes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.